Elevance Health Inc

NYSE:ELVUnited States

Yesterday

Show headlines and story abstract

• Elevance Health Announces Appearance at Goldman Sachs 45(th) Annual Global Healthcare Conference, from 8 hours ago by Dow Jones

  8 hours ago by Dow Jones
  Companies Mentioned: ELV
  INDIANAPOLIS--(BUSINESS WIRE)--May 30, 2024--
  Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Goldman Sachs 45(th) Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the "Investors" link. You may also access the link here.
  

• DJ Elevance Health Is Maintained at Overweight by JP Morgan, from 11 hours ago by Dow Jones

  11 hours ago by Dow Jones
  Companies Mentioned: ELV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ELV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 30, 2024 13:54 ET (17:54 GMT)
  

• JPMorgan Adjusts Price Target on Elevance Health to $631 From $628, from 16 hours ago by MT Newswires

  16 hours ago by MT Newswires
  Companies Mentioned: ELV
  08:43 AM EDT, 05/30/2024 (MT Newswires) -- Elevance Health (ELV) has an average buy rating and a price target range of $520 to $665, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major ...

• DJ Elevance Health Initiated at Outperform by Baird, from 18 hours ago by Dow Jones

  18 hours ago by Dow Jones
  Companies Mentioned: ELV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ELV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 30, 2024 06:06 ET (10:06 GMT)
  

• Baird Initiates Elevance Health With Outperform Rating, $649 Price Target, from 19 hours ago by MT Newswires

  19 hours ago by MT Newswires
  Companies Mentioned: ELV
  05:44 AM EDT, 05/30/2024 (MT Newswires) -- Elevance Health (ELV) has an average rating of buy and price targets ranging from $520 to $665, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from ...